A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors

NCT03982212 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma
Squamous Cell Carcinoma
Basal Cell Carcinoma

Interventions

DRUG: Copaxone

Sponsor

University of Kansas Medical Center